HighTower Advisors LLC Has $153.01 Million Stake in Stryker Corporation $SYK

HighTower Advisors LLC lifted its stake in Stryker Corporation (NYSE:SYK) by 8.3% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 486,005 shares of the medical technology company’s stock after buying an additional 37,269 shares during the period. HighTower Advisors LLC owned approximately 0.13% of Stryker worth $153,014,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also added to or reduced their stakes in SYK. Gables Capital Management Inc. bought a new stake in Stryker during the second quarter worth about $25,000. Kilter Group LLC bought a new position in Stryker in the 2nd quarter valued at about $25,000. Highland Investment Advisors LLC acquired a new position in shares of Stryker in the 2nd quarter valued at approximately $25,000. Godfrey Financial Associates Inc. bought a new stake in shares of Stryker during the 4th quarter worth approximately $26,000. Finally, Sankala Group LLC bought a new stake in shares of Stryker during the 4th quarter worth approximately $26,000. Institutional investors and hedge funds own 77.09% of the company’s stock.

Analyst Ratings Changes

A number of research analysts recently issued reports on the stock. UBS Group assumed coverage on shares of Stryker in a research note on Tuesday, July 28th. They issued a “buy” rating and a $400.00 price objective on the stock. Royal Bank Of Canada cut their target price on Stryker from $435.00 to $420.00 and set an “outperform” rating for the company in a research note on Friday, July 31st. JPMorgan Chase & Co. reduced their target price on Stryker from $400.00 to $350.00 and set an “overweight” rating on the stock in a report on Friday, July 31st. Citigroup reiterated a “buy” rating on shares of Stryker in a research note on Thursday, August 13th. Finally, Wall Street Zen upgraded Stryker from a “hold” rating to a “buy” rating in a research report on Saturday, August 8th. One research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat, Stryker currently has a consensus rating of “Moderate Buy” and an average price target of $386.28.

Insider Activity at Stryker

In other news, Director Ronda E. Stryker sold 300,000 shares of the firm’s stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $335.90, for a total transaction of $100,770,000.00. Following the completion of the transaction, the director owned 2,301,375 shares of the company’s stock, valued at approximately $773,031,862.50. This trade represents a 11.53% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Dylan Crotty sold 441 shares of Stryker stock in a transaction on Friday, August 21st. The stock was sold at an average price of $328.61, for a total transaction of $144,917.01. Following the transaction, the insider owned 6,102 shares in the company, valued at approximately $2,005,178.22. This trade represents a 6.74% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 351,267 shares of company stock worth $118,197,701 in the last quarter. 4.60% of the stock is owned by insiders.

Stryker Stock Performance

NYSE SYK opened at $302.92 on Monday. The firm’s fifty day moving average price is $328.84 and its two-hundred day moving average price is $329.48. The stock has a market cap of $116.19 billion, a PE ratio of 31.39, a PEG ratio of 1.90 and a beta of 0.76. Stryker Corporation has a fifty-two week low of $281.00 and a fifty-two week high of $396.37. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.33 and a current ratio of 2.16.

Stryker (NYSE:SYK) last announced its quarterly earnings results on Thursday, July 30th. The medical technology company reported $3.69 EPS for the quarter, beating analysts’ consensus estimates of $3.49 by $0.20. Stryker had a return on equity of 23.63% and a net margin of 14.43%.The company had revenue of $6.59 billion during the quarter, compared to analysts’ expectations of $6.58 billion. During the same period in the prior year, the company earned $3.13 EPS. Stryker’s revenue was up 9.4% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. On average, equities analysts expect that Stryker Corporation will post 15.03 EPS for the current fiscal year.

Stryker Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be issued a $0.88 dividend. This represents a $3.52 dividend on an annualized basis and a yield of 1.2%. The ex-dividend date is Wednesday, September 30th. Stryker’s dividend payout ratio (DPR) is 36.48%.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.